Skip to main content

Advertisement

SpringerLink
Log in

Expert Consensus on clinical application of FDG PET/CT in infection and inflammation

  • Others
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

To further promote the clinical application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in infection and inflammation and standardize the diagnostic process, the experts in relevant fields in China carried out discussion and formed the Expert Consensus on the clinical application of FDG PET/CT in infection and inflammation. This consensus is intended to provide a reference for imaging physicians to select a reasonable diagnostic plan. However, it should be noted that it couldn’t include or solve all the problems in clinical operation. Imaging physicians and technicians should develop a comprehensive and reasonable diagnostic procedure according to their professional knowledge, clinical experience and currently available medical resources when facing specific patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Goldman L, Schafer AI. Goldman-cecil medicine. 25thth ed ed. Amsterdam: Elsevier; 2016.

    Google Scholar 

  2. Vinay K, Abul KA, Jon CA. Robbins basic pathology. 10thth ed ed. Amsterdam: Elsevier; 2018.

    Google Scholar 

  3. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeosxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972–80.

    CAS  PubMed  Google Scholar 

  4. Vaidyanathan S, Patel CN, Scarsbrook AF, Chowdhury FU. FDG PET/CT in infection and inflammation—current and emerging clinical applications. Clin Raiol. 2015;70(7):787–800.

    CAS  Google Scholar 

  5. Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, et al. EANM/SNMMI Guideline for 18F-FDG Use in Inflammation and Infection. J Nucl Med. 2013;54(4):647–57.

    PubMed  Google Scholar 

  6. Besson FL, Chaumet-Riffaud P, Playe M, Noel N, Lambotte O, Goujard C, et al. Contribution of (18)F-FDG PET in the diagnostic assessment of fever of unknown origin (FUO): a stratification-based meta-analysis. Eur J Nucl Med Mol Imaging. 2016;43(10):1887–955.

    CAS  PubMed  Google Scholar 

  7. Takeuchi M, Dahabreh IJ, Nihashi T, Iwata M, Varghese GM, Terasawa T. Nuclear Imaging for Classic Fever of Unknown Origin: Meta-Analysis. J Nucl Med. 2016;57(12):1913–9.

    CAS  PubMed  Google Scholar 

  8. Schönau V, Vogel K, Englbrecht M, Wacker J, Schmidt D, Manger B, et al. The value of 18F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study. Ann Rheum Dis. 2018;77(1):70–7.

    PubMed  Google Scholar 

  9. Wang Q, Li YM, Li Y, Hua FC, Wang QS, Zhang XL, et al. 18F-FDG PET/CT in fever of unknown origin and inflammation of unknown origin: a Chinese multi-center study. Eur J Nucl Med Mol Imaging. 2019;46:159–65.

    PubMed  Google Scholar 

  10. Kim SJ, Lee SW, Jeong SY, Pak K, Kim K. A systematic review and meta-analysis of 18F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography for detection of infected prosthetic vascular grafts. J Vasc Surg. 2019;70(1):307–13.

    PubMed  Google Scholar 

  11. Rojoa D, Kontopodis N, Antoniou SA, Ioannou CV, Antoniou GA. 18F-FDG PET in the diagnosis of vascular prosthetic graft infection: A diagnostic test accuracy meta-analysis. Eur J Vasc Endovasc Surg. 2019;57(2):292–301.

    PubMed  Google Scholar 

  12. Sah BR, Husmann L, Mayer D, Scherrer A, Rancic Z, Puippe G, et al. Diagnostic performance of 18F-FDG-PET/CT in vascular graft infections. Eur J Vasc Endovasc Surg. 2015;49(4):455–64.

    PubMed  Google Scholar 

  13. Husmann L, Ledergerber B, Anagnostopoulos A, Stolzmann P, Sah BR, Burger IA, et al. The role of FDG PET/CT in therapy control of aortic graft infection. Eur J Nucl Med Mol Imaging. 2018;45(11):1987–97.

    PubMed  Google Scholar 

  14. San S, Ravis E, Tessonier L, Philip M, Cammilleri S, Lavagna F, et al. Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in infective endocarditis. J Am Coll Cardiol. 2019;74(8):1031–40.

    CAS  PubMed  Google Scholar 

  15. Granados U, Fuster D, Pericas JM, Llopis JL, Ninot S, Quintana E, et al. Diagnostic Accuracy of 18F-FDG PET/CT in Infective endocarditis and implantable cardiac electronic device infection: A cross-sectional study. J Nucl Med. 2016;57(11):1726–32.

    CAS  PubMed  Google Scholar 

  16. Mahmood M, Kendi AT, Ajmal S, Farid S, O'Horo JC, Chareonthaitawee P, et al. Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis. J Nucl Cardiol. 2019;26(3):922–35.

    PubMed  Google Scholar 

  17. Li Y, Wang Q, Wang L. Localization and etiologic diagnosis of suspected pacemaker-related infection with 18F-FDG PET/CT. Chin J Nucl Med Mol Imaging. 2017;37(5):284–8 [Article in Chinese].

    Google Scholar 

  18. Kiran M, Donnelly TD, Armstrong C, Kapoor B, Kumar G, Peter V. Diagnostic utility of fluorodeoxyglucose positron emission tomography in prosthetic joint infection based on MSIS criteria. Bone Joint J. 2019;101-B(8):910–4.

    CAS  PubMed  Google Scholar 

  19. Kumar R, Kumar R, Kumar V, Malhotra R. Potential clinical implication of (18) F-FDG PET/CT in diagnosis of periprosthetic infection and its comparison with (18) F-Fluoride PET/CT. J Med Imaging Radiat Oncol. 2016;60(3):315–22.

    PubMed  Google Scholar 

  20. Jin H, Yuan L, Li C, Kan Y, Hao R, Yang J. Diagnostic performance of FDG-PET or PET/CT in prosthetic infection after arthroplasty: a meta-analysis. Q J Nucl Med Mol Imaging. 2014;58:85–93.

    CAS  PubMed  Google Scholar 

  21. Basu S, Kwee TC, Saboury B, Garino JP, Nelson CL, Zhuang H, et al. FDG-PET for diagnosing infection in hip and knee prostheses: prospective study in 221 prostheses and subgroup comparison with combined 111In-labeled leukocyte/99mTc-sulfur colloid bone marrow imaging in 88 prostheses. Clin Nucl Med. 2014;39:609–15.

    PubMed  PubMed Central  Google Scholar 

  22. Lankinen P, Seppanen M, Mattila K, Kallajoki M, Knuuti J, Aro HT. Intensity of (18)F-FDG PET uptake in culture-negative and culture-positive cases of chronic osteomyelitis. Contrast Media Mol Imaging. 2017;2017:9754293.

    PubMed  PubMed Central  Google Scholar 

  23. van Vliet KE, de Jong VM, Termaat MF, Schepers T, van Eck-Smit BLF, Goslings JC, et al. FDG-PET/CT for differentiating between aseptic and septic delayed union in the lower extremity. Arch Orthop Trauma Surg. 2018;138(2):189–94.

    PubMed  Google Scholar 

  24. Demirev A, Weijers R, Geurts J, Mottaghy F, Walenkamp G, Brans B. Comparison of [18F] FDG PET/CT and MRI in the diagnosis of active osteomyelitis. Skeletal Radiol. 2014;43(5):665–72.

    PubMed  Google Scholar 

  25. Schmitz A, Risse JH, Grünwald F, Gassel F, Biersack HJ, Schmitt O. Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results. Eur Spine J. 2001;10:534–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Sminds C, Kouijzer IJ, Vos FJ, Sprong T, Hosman AJ, de Rooy JW, et al. A comparison of the diagnostic value of MRI and18F-FDG-PET/CT in suspected spondylodiscitis. Infection. 2017;45(1):41–9.

    Google Scholar 

  27. Yin Y, Liu X, Yang X, Guo J, Wang Q, Chen L. Diagnostic value of FDG-PET versus magnetic resonance imaging for detecting spondylitis: a systematic review and meta-analysis. Spine J. 2018;18(12):2323–32.

    PubMed  Google Scholar 

  28. Kouijzer IJ, Blokhuis GJ, Draaisma JM, Oyen WJ, de Geus-Oei LF, Bleeker-Rovers CP. 18F-FDG PET/CT in detecting metastatic infection in children. Clin Nucl Med. 2016;41(4):278–81.

    PubMed  Google Scholar 

  29. Berrevoets MAH, Kouijzer IJE, Aarntzen EHJG, Janssen MJR, De Geus-Oei LF, Wertheim HFL, et al. 18F-FDG PET/CT optimizes treatment in Staphylococcus Aureus bacteremia and is associated with reduced mortality. J Nucl Med. 2017;58(9):1504–10.

    CAS  PubMed  Google Scholar 

  30. Vos FJ, Bleeker-Rovers CP, Sturm PD, Krabbe PF, van Dijk AP, Cuijpers ML, et al. 18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia. J Nucl Med. 2010;51(8):1234–40.

    PubMed  Google Scholar 

  31. Brøndserud MB, Pedersen C, Rosenvinge FS, Høilund-Carlsen PF, Hess S. Clinical value of FDG-PET/CT in bacteremia of unknown origin with catalase-negative gram-positive cocci or Staphylococcus aureus. Eur J Nucl Med Mol Imaging. 2019;46(6):1351–8.

    PubMed  Google Scholar 

  32. Lantinga MA, Drenth JP, Gevers TJ. Diagnostic criteria in renal and hepatic cyst infection. Nephrol Dial Transplant. 2015;30(5):744–51.

    CAS  PubMed  Google Scholar 

  33. Bobot M, Ghez C, Gondouin B, Sallée M, Fournier PE, Burtey S, et al. Diagnostic performance of [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography in cyst infection in patients with autosomal dominant polycystic kidney disease. Clin Microbiol Infect. 2016;22(1):71–7.

    CAS  PubMed  Google Scholar 

  34. Jouret F, Lhommel R, Beguin C, Devuyst O, Pirson Y, Hassoun Z, et al. Positron-emission computed tomography in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2011;6:1644–50.

    PubMed  Google Scholar 

  35. Polizzotto MN, Millo C, Uldrick TS, Aleman K, Whatley M, Wyvill KM, et al. 18F-fluorodeoxyglucose positron emission tomography in kaposi sarcoma herpesvirus-associated multicentric castleman disease: Correlation with activity, severity, inflammatory and virologic parameters. J Infect Dis. 2015;212(8):1250–60.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Sathekge M, Maes A, Van de Wiele C. FDG-PET imaging in HIV infection and tuberculosis. Semin Nucl Med. 2013;43(5):349–66.

    PubMed  Google Scholar 

  37. Sathekge M, Goethals I, Maes A, van de Wiele C. Positron emission tomography in patients suffering from HIV-1 infection. Eur J Nucl Med Mol Imaging. 2009;36(7):1176–84.

    PubMed  Google Scholar 

  38. Liu Y. Demonstrations of AIDS-associated malignancies and infections at FDG PET-CT. Ann Nucl Med. 2011;25(8):536–46.

    PubMed  Google Scholar 

  39. Kim IJ, Lee JS, Kim SJ, Kim YK, Jeong YJ, Jun S, et al. Double-phase 18F-FDG PET-CT for determination of pulmonary tuberculoma activity. Eur J Nucl Med Mol Imaging. 2008;35(4):808–14.

    PubMed  Google Scholar 

  40. Sathekge M, Maes A, D'Asseler Y, Vorster M, Gongxeka H, Van de Wiele C. Tuberculous lymphadenitis: FDG PET and CT findings in responsive and nonresponsive disease. Eur J Nucl Med Mol Imaging. 2012;39(7):1184–90.

    PubMed  Google Scholar 

  41. Malherbe ST, Shenai S, Ronacher K, Loxton AG, Dolganov G, Kriel M, et al. Persisting PET-CT lesion activity and Mycobacterium tuberculosis mRNA after pulmonary tuberculosis cure. Nat Med. 2016;22(10):1094–100.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Lawal I, Fourie B, Mathebula M, Moagi I, Lengana T, Moeketsi N, et al. FDG-PET/CT as a non-invasive biomarker for assessing adequacy of treatment and predicting relapse in patients treated for pulmonary tuberculosis. J Nucl Med. 2019. https://doi.org/10.2967/jnumed.119.233783.

    Article  PubMed  Google Scholar 

  43. Ohira H, Ardle BM, deKemp RA, Nery P, Juneau D, Renaud JM, et al. Inter- and intraobserver agreement of 18F-FDG PET/CT image interpretation in patients referred for assessment of cardiac sarcoidosis. J Nucl Med. 2017;58(8):1324–9.

    CAS  PubMed  Google Scholar 

  44. Tang R, Wang JT, Wang L, Le K, Huang Y, Hickey AJ, et al. Impact of patient preparation on the diagnostic performance of 18F-FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis. Clin Nucl Med. 2016;41(7):327–39.

    Google Scholar 

  45. Lu Y, Grant C, Xie K, Sweiss NJ. Suppression of myocardial 18F-FDG uptake through prolonged high-fat, high-protein, and very-low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. Clin Nucl Med. 2017;42(2):88–94.

    PubMed  Google Scholar 

  46. Ahmadian A, Pawar S, Govender P, Berman J, Ruberg FL, Miller EJ. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis. J Nucl Cardiol. 2017;24(2):413–24.

    PubMed  Google Scholar 

  47. Duftner C, Dejaco C, Sepriano A, Falzon L, Schmidt WA, Ramiro S. Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations. RMD Open. 2018;4(1):e000612.

    PubMed  PubMed Central  Google Scholar 

  48. Fuchs M, Briel M, Daikeler T, Walker UA, Rasch H, Berg S, et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging. 2012;39(2):344–53.

    PubMed  Google Scholar 

  49. Hooisma GA, Balink H, Houtman PM, Slart RH, Lensen KD. Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter retrospective study. Clin Rheumatol. 2012;31(5):873–5.

    Google Scholar 

  50. Zhang Y, Shen M. Value of positron emission tomography/computed tomography in the diagnosis and disease activity assessment of systemic vasculitis. Chin J Allergy Clin Immunol. 2014;8(1):70–5 [Article in Chinese].

    Google Scholar 

  51. Nielsen BD, Gormsen LC, Hansen IT, Keller KK, Therkildsen P, Hauge EM. Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy. Eur J Nucl Med Mol Imaging. 2018;45(7):1119–28.

    CAS  PubMed  Google Scholar 

  52. Grayson PC, Alehashemi S, Bagheri AA, Civelek AC, Cupps TR, Kaplan MJ, et al. 18F-Fluorodeoxyglucose-positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis. Arthritis Rheumatol. 2018;70(3):439–49.

    PubMed  PubMed Central  Google Scholar 

  53. Bleeker-Rovers CP, Bredie SJ, van der Meer JW, Corstens FH, Oyen WJ. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med. 2003;61(10):323–9.

    CAS  PubMed  Google Scholar 

  54. Kemna MJ, Vandergheynst F, Vöö S, Blocklet D, Nguyen T, Timmermans SA, et al. Positron emission tomography scanning in anti-neutrophil cytoplasmic antibodies-associated vasculitis. Medicine (Baltimore). 2015;94(20):e747.

    CAS  Google Scholar 

  55. Frary EC, Hess S, Gerke O, Laustrup H. 18F-fluoro-deoxy-glucose positron emission tomography combined with computed tomography can reliably rule-out infection and cancer in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis suspected of disease relapse. Medicine (Baltimore). 2017;96(30):e7613.

    Google Scholar 

  56. Trad S, Bensimhon L, El Hajjam M, Chinet T, Wechsler B, Saadoun D. 18F-fluorodeoxyglucose-positron emission tomography scanning is a useful tool for therapy evaluation of arterial aneurysm in Behçet's disease. Joint Bone Spine. 2013;80(4):420–3.

    PubMed  Google Scholar 

  57. Dong MJ, Wang CQ, Zhao K, Wang GL, Sun ML, Liu ZF, et al. 18F-FDG PET/CT in patients with adult-onset Still's disease. Clin Rheumatol. 2015;34(12):2047–56.

    PubMed  Google Scholar 

  58. Jiang L, Xiu Y, Gu T, Dong C, Wu B, Shi H. Imaging characteristics of adult onset Still's disease demonstrated with 18F-FDG PET/CT. Mol Med Rep. 2017;16(3):3680–6.

    CAS  PubMed  Google Scholar 

  59. Yamashita H, Kubota K, Takahashi Y, Minamimoto R, Morooka M, Kaneko H, et al. Clinical value of (18)F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature. Mod Rheumatol. 2014;24(4):645–50.

    PubMed  Google Scholar 

  60. Li Y, Zhou Y, Wang Q. Multiple values of 18F-FDG PET/CT in idiopathic inflammatory myopathy. Clin Rheumatol. 2017;36(10):2297–305.

    PubMed  Google Scholar 

  61. Martis N, Viau P, Zenone T, Andry F, Grados A, Ebbo M, et al. Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis. Eur Radiol. 2019;29(12):6708–16.

    PubMed  Google Scholar 

  62. Mahmmod S, Martínez R, de Llano S. 18F-FDG PET detection of unknown primary malignancy in dermatomyositis. Clin Nucl Med. 2012;37(8):e204–205.

    Google Scholar 

  63. Kundrick A, Kirby J, Ba D, Leslie D, Olsen N, Foulke G. Positron emission tomography costs less to patients than conventional screening for malignancy in dermatomyositis. Semin Arthritis Rheum. 2019;49(1):140–4.

    PubMed  Google Scholar 

  64. Yamashita H, Kubota K, Takahashi Y, Minaminoto R, Morooka M, Ito K, et al. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis. Mod Rheumatol. 2012;22(5):705–11.

    PubMed  Google Scholar 

  65. Rehak Z, Sprlakova-Pukova A, Kazda T, Fojtik Z, Vargova L, Nemec P. 18F-FDG PET/CT in polymyalgia rheumatica-a pictorial review. Br J Radiol. 2017;90(1076):20170198.

    PubMed  PubMed Central  Google Scholar 

  66. Kubota K, Yamashita H, Mimori A. Clinical Value of FDG-PET/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis. Semin Nucl Med. 2017;47(4):408–24.

    PubMed  Google Scholar 

  67. Lei W, Zeng H, Zeng DX, Zhang B, Zhu YH, Jiang JH, et al. (18)F-FDG PET-CT: a powerful tool for the diagnosis and treatment of relapsing polychondritis. Br J Radiol. 2016;89(1057):20150695.

    PubMed  Google Scholar 

  68. Qiu LH, Wang Q. The value of 18F-flurodeoxyglucose positron emission tomography/computed tomography for detecting the relapsing polychondritis in patients with fever of unknown origin. Chin J Rheumatol. 2017;21(12):841–3 [Article in Chinese].

    Google Scholar 

  69. Beckers C, Ribbens C, André B, Marcelis S, Kaye O, Mathy L, et al. Assessment of disease activity in rheumatoid arthritis with 18F-FDG PET. J Nucl Med. 2004;45(6):956–64.

    CAS  PubMed  Google Scholar 

  70. Kubota K, Ito K, Morooka M, Mitsumoto T, Kurihara K, Yamashita H, et al. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints. Ann Nucl Med. 2009;23:783–91.

    PubMed  Google Scholar 

  71. Kubota K, Ito K, Morooka M, Minamimoto R, Miyata Y, Yamashita H, et al. FDG PET for rheumatoid arthritis: basic considerations and whole-body PET/CT. Ann N Y Acad Sci. 2011;1228:29–38.

    PubMed  Google Scholar 

  72. Zhang J, Chen H, Ma Y, Xiao Y, Niu N, Lin W, et al. Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective chort study. Eur J Nucl Med Mol Imaging. 2014;41(8):1624–34.

    CAS  PubMed  PubMed Central  Google Scholar 

  73. Zhao Z, Wang Y, Guan Z, Jin J, Huang F, Zhu J. Utility of FDG-PET/CT in the diagnosis of IgG4-related diseases. Clin Exp Rheumatol. 2016;34(1):119–25.

    PubMed  Google Scholar 

  74. Berti A, Della-Torre E, Gallivanone F, Canevari C, Milani R, Lanzillotta M, et al. Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease. Rheumatology. 2017;56(12):2084–92.

    CAS  PubMed  Google Scholar 

  75. Mavrogeni S, Markousis-Mavrogenis G, Kolovou G. IgG4-related cardiovascular disease. The emerging role of cardiovascular imaging. Eur J Radiol. 2017;86:169–75.

    PubMed  Google Scholar 

  76. Curiel R, Akin EA, Beaulieu G, DePalma L, Hashefi M. PET/CT imaging in systemic lupus erythematosus. Ann NY Acad Sci. 2011;1228:71–80.

    PubMed  Google Scholar 

  77. Makis W, Ciarallo A, Gonzalez-Verdecia M, Probst S. Systemic lupus erythematosus associated pitfalls on 18F-FDG PET/CT: reactive follicular hyperplasia, Kikuchi-Fujimoto disease, inflammation and lymphoid hyperplasia of the spleen mimicking lymphoma. Nucl Med Mol Imaging. 2018;52(1):74–9.

    CAS  PubMed  Google Scholar 

  78. Boellaard R, Delgado-Bolton R, Oyen W, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328–54.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This consensus is based on the Sino-Japanese cooperative research work in nuclear medicine. In the related research work, it has been guided and supported by Japanese experts, such as professors Jun Hatazawa, Hiroshi Toyama and Kazuo Kubota. We hereby express our thanks.

Funding

This study has no funding.

Author information

Author notes

  1. Yaming Li and Qian Wang contributed equally to this work.

Authors and Affiliations

  1. Department of Nuclear Medicine, the First Hospital of China Medical University, No.155 Nanjing North Street, Heping District, Shenyang, Liaoning, 110001, People’s Republic of China

    Yaming Li & Xuena Li

  2. Department of Nuclear Medicine, Peking University People’s Hospital, No.11 Xizhimen South Street, Xicheng District, Beijing, 100044, People’s Republic of China

    Qian Wang & Yuan Li

  3. Department of Nuclear Medicine, Affiliated Hospital of Inner Mongolia Medical University, No.1 Tongdao North Street, Huimin District, Hohhot, 010050, People’s Republic of China

    Xuemei Wang

  4. Department of Nuclear Medicine and Minnan PET Center, Xiamen Cancer Hospital of the First Affiliated Hospital of Xiamen University, No.55 Zhenhai Street, Siming District, Xiamen, 361003, People’s Republic of China

    Hua Wu

  5. PET Center, Nanfang Hospital, Southern Medical University, No.1838 North Guangzhou Avenue, Baiyun District, Guangzhou, 510515, People’s Republic of China

    Quanshi Wang

  6. Department of Nuclear Medicine, Beijing Hospital, National Center of Gerontology, No.1 Dongdan Dahua Street, Dongcheng district, Beijing, 100730, People’s Republic of China

    Zhiming Yao

  7. Department of Nuclear Medicine, the First Affiliated Hospital of Fujian Medical University, No.20 Chazhong Street, Fuzhou, 350005, People’s Republic of China

    Weibing Miao

  8. Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, Wuhan, 430030, People’s Republic of China

    Xiaohua Zhu

  9. PET Center, Huashan Hospital, Fudan University, 518 East Wuzhong Road, Shanghai, 200235, People’s Republic of China

    Fengchun Hua

  10. Department of Nuclear Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, 725 South Wanping Road, Shanghai, 200032, People’s Republic of China

    Fengchun Hua

  11. Department of Nuclear Medicine, Beijing Anzhen Hospital, Capital Medical University, No.2 Anzhen Street, Chaoyang District, Beijing, 100029, People’s Republic of China

    Xiaoli Zhang

  12. Department of Nuclear Medicine, Shanghai Changhai Hospital of the Second Military Medical University, No.168 Changhai Road, Yangpu District, Shanghai, 200433, People’s Republic of China

    Chao Cheng

  13. Department of Nuclear Medicine, Peking University Third Hospital, No.49 North Garden Road, Haidian District, Beijing, 100191, People’s Republic of China

    Weifang Zhang

  14. Department of Nuclear Medicine, WeiLun PET Center, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, No. 106 Zhongshan Second Street, Yuexiu District, Guangzhou, 510080, People’s Republic of China

    Qingyi Hou

  15. Department of Nuclear Medicine, Shenzhen People’s Hospital, No. 1017 Dongmen North Street, Luohu District, Shenzhen, 518020, People’s Republic of China

    Xiao-Feng Li

Authors
  1. Yaming Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qian Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xuemei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xuena Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hua Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Quanshi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zhiming Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Weibing Miao
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xiaohua Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Fengchun Hua
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Xiaoli Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Chao Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Weifang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Qingyi Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Yuan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Xiao-Feng Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yaming Li or Qian Wang.

Ethics declarations

Conflict of interest

No potential conflicts of interest were disclosed.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Y., Wang, Q., Wang, X. et al. Expert Consensus on clinical application of FDG PET/CT in infection and inflammation. Ann Nucl Med 34, 369–376 (2020). https://doi.org/10.1007/s12149-020-01449-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-020-01449-8

Keywords

Search

Navigation